Published in

Lippincott, Williams & Wilkins, Transplantation, 12(89), p. 1471-1475, 2010

DOI: 10.1097/tp.0b013e3181dc13e7

Links

Tools

Export citation

Search in Google Scholar

C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection

Journal article published in 2010 by Gideon Hönger, Markus Wahrmann, Patrizia Amico, Helmut Hopfer ORCID, Georg A. Böhmig, Stefan Schaub
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Recent studies indicate that not all low-level donor-specific human leukocyte antigen (HLA) antibodies (HLA-DSA) (i.e., positive by solid-phase assays, negative by complement-dependent cytotoxic-crossmatch) have a detrimental clinical impact. The aim of this study was to investigate whether the pretransplant C4d-fixing capability allows distinguishing harmful from presumably clinically irrelevant HLA-DSA.